Latest News
-
How heparin helps in COVID care
Heparin is an effective treatment for moderately ill COVID-19 patients but not for those with critical illness, according to the findings of a major international study. Read more
-
Protein target could help with aggressive cancer treatment
A protein in tumour cells could be targeted to treat some types of aggressive cancer including those of the brain, blood, skin, and kidney, scientists have reported. Read more
-
Long-COVID ‘rare’ in children – UK study
Most children who contract symptomatic COVID-19 recover within six days and long-COVID is rare, according to a new UK study. Read more
-
Artificial pancreas trial for people with type 2 diabetes
An artificial pancreas is being trialled for people with type 2 diabetes who also need kidney dialysis, it was revealed yesterday. Read more
-
New HIV vaccine trial launched
A major study of a t-cell vaccine for HIV is under way, it has been announced. Read more
-
COVID vaccine effective with rituximab
COVID-19 vaccination can effectively produce antibodies in patients on rituximab treatment, according to a new European study. Read more
-
Trial will seek to allay pregnancy vaccine hesitancy
A specific clinical trial is to investigate the best COVID-19 vaccine schedule for pregnant women, it has been announced. Read more
-
Myopia in children linked to COVID-19 pandemic
An increase in myopia among children could be linked to the COVID-19 pandemic, a new study out today has suggested. Read more
-
Unvaccinated pregnant women hospitalised with COVID-19
Pregnant women are being urged to have the COVID-19 vaccination after 200 were admitted to hospital last week with the virus – almost all of whom were unvaccinated. Read more
-
Gene therapy programme launched for neurodegenerative diseases
An innovative gene therapy programme has been launched that could lead to novel treatments for neurodegenerative diseases. Read more